skip to main content
Global Search Configuration

Gain a deeper understanding of the implications of the Regenerative Medicine Advanced Therapies (RMAT) designation and the significance of its support and advancement by the FDA in this webinar recording, "RMAT Designation – Impact on Regenerative Medicine Sector".

Held in partnership with the Alliance for Regenerative Medicine (ARM), experts from both ARM and Informa Pharma Intelligence explored the RMAT designation and its implications.

In this recording You will gain insight into:

  • How the RMAT designation supports delivery of safe and effective gene and cell therapies to patients in need
  • How RMAT compares with other accelerated approval programs available to product sponsors
  • How the FDA supports and views the RM/AT sector


Read also

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: